IL6RIL6 chimera for the treatment of neurodegenerative diseases
US7201896B1 · kind B1 · utility
3Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 21, 2000 |
| Grant date | Apr 10, 2007 |
| Priority date | — |
| Expiry date | May 30, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of IL6RIL6 chimera in the treatment and prevention of neurological diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.